Most-used short-read sequencers ranked by how many preprints say they used each
Short-read sequencers read DNA a few hundred bases at a time, accurately and cheaply. Most genome, exome and single-cell data comes from them. Updated daily (as of Nov 16)
Illumina NovaSeq X is the most-used short-read sequencer.
Illumina NovaSeq X had 44% of the uses in Jun–Nov 2026, up from 33% the year before. Illumina NextSeq is second with 40%.
| # | Platform | Last 6 months | Growth | Share | Total | By year |
|---|---|---|---|---|---|---|
| 1 | 1,309 preprints | +47% | 44%up from 33% | 3,525 38% | ||
| 2 | 1,169 preprints | −19% | 40%down from 53% | 4,385 47% | ||
| 3 | 296 preprints | +6% | 10%same as a year earlier | 946 10% | ||
| 4 | 171 preprints | +50% | 6%up from 4% | 447 5% |
Last 6 months is Jun–Nov 2026. Growth compares it with Jun–Nov 2025, as a share of all preprints. Total counts every preprint since April 2025 that says it used the platform.
Top institutions for each platform
Stanford University92
University of California, San Francisco61
University of California, Los Angeles53
University of California, San Diego51
Johns Hopkins University48
University of Washington61
Stanford University54
University of Pennsylvania48
Institut Pasteur48
University of Pittsburgh40
Counts every preprint since April 2025, by the corresponding author's institution.
Element AVITI is growing fastest.
Up 50% in Jun–Nov 2026 vs the previous year as a share of all preprints. Illumina NovaSeq X was up 47%, MGI DNBSEQ up 6% and Illumina NextSeq down 19%. All four together grew 8%. Compare side by side: AVITI vs NovaSeq X →
NovaSeq X
NextSeq
DNBSEQ
AVITI
The last bar is the quarter so far.
Latest preprints using short-read sequencing
How we count which preprints use each platform
An AI model reads each preprint in full — its text, its tables and its supplementary files — and lists the products the authors used. A preprint counts for a platform when that record says the lab used it in this work, not when it only analyzed data others made with it or only mentioned it. Each preprint counts once, by its first version, if it was first posted on bioRxiv or medRxiv in April 2025 or later. We read new preprints within days of posting, so the newest ones (through Nov 16, 2026) are already counted, but those days are not complete yet. Six-month counts and growth figures stop at Nov 12, 2026, the last day nearly every preprint has been read, and charts draw a quarter that is still being counted in a paler color. A preprint that used two platforms counts for both. Each title links to the preprint on bioRxiv or medRxiv; we show no preprint text and no author names. Updated daily, most recently on Nov 16, 2026.